Wells Fargo’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-25,000
Closed -$931K 7159
2021
Q2
$931K Buy
+25,000
New +$923K ﹤0.01% 4253

Other funds holding GDRX

Wells Fargo's GDRX Position: Q1 2026 in Review

Wells Fargo increased its GoodRx Holdings (GDRX) stake by 85% in Q1 2026, buying an estimated $326K and bringing the position to 303,307 shares worth $594K. The position accounts for ﹤0.01% of the portfolio, ranked #4055.

Wells Fargo first reported a position in GDRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $5.67M in Q2 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Wells Fargo held 303,307 shares of GoodRx Holdings worth $594K as of Q1 2026.
  • Wells Fargo bought 139,018 GoodRx Holdings shares in Q1 2026, an estimated $326K.
  • GoodRx Holdings made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4055 holding.
  • Wells Fargo first reported a position in GoodRx Holdings in Q3 2020 and has held it in 23 quarters since.
  • Wells Fargo's GoodRx Holdings position peaked at $5.67M in Q2 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.